Therapeutics Acquisition TXAC 深 沪
已收盘 09-09 16:00:00 美东时间
12.96
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 12.96
- 总市值 2.32亿
- 52周最高 21.44
- 市盈率 静 12.66
- 换手率 0.00%
- 52周最低 11.11
- 委 比 0.00%
- 总股本 1786.99万
- 历史最高 21.44
- 量 比 0
- 振 幅 0.00%
- 历史最低 11.11
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition
Bristol Myers Squibb is acquiring Orbital Therapeutics for $1.5 billion, expanding its RNA and in vivo CAR T-cell therapy portfolio.
2025-10-10 22:32
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?
Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.
2025-03-28 00:50
快讯 | NRX制药公司 - 临时首席财务官理查德·纳里多将专注于Hope Therapeutics收购
NRX Pharmaceuticals Inc - Interim-CFO Richard Narido to Focus on Hope Therapeut...
2024-11-19 05:05
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Closing of $135.7 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option To Purchase Additional Shares
Therapeutics Acquisition Corp. (Nasdaq: TXAC) (the “Company”) announced today t...
2021-07-13 00:02
屡创新高！SPAC募资额225亿美元，IPO数破纪录
智通财经APP获悉，美股市场在8月4日完成三笔SPAC发行，今年迄今，SPAC的IPO数量已超去年创记录的数量。截至目前，已有60个SPAC筹集了225亿美元...
2020-08-06 16:40
